Samsung Group companies will jointly invest $10 million in C2N Diagnostics LLC, a U.S.-based company specializing in blood-based Alzheimer’s disease diagnostics, in their broader push into next-generation healthcare technologies.Samsung C&T Corp., the de facto holding company of Samsung Group, announced on Thursday that it has decided to invest $10 million in C2N through the Samsung Life Science Fund, created jointly by Samsung C&T, Samsung Biologics Co.and Samsung Bioepis Co.and managed by their affiliated investment arm Samsung Venture Investment Corp.
Food and Drug Administration (FDA) approval for its Alzheimer’s disease-specific fluid biomarker tests, which could become a game-changer in early detection and treatment of the cognitive impairment.“Samsung’s important investment will allow C2N to further strengthen our capabilities, expand our commercial scale and innovate next-generation diagnostic tests that can improve patients’ lives,” C2N CEO Dr.
C2N, a specialty diagnostics company for brain health, offers a blood test that is a safer and more cost-effective alternative to traditional diagnostic methods, such as amyloid PET-CT scans or cerebrospinal fluid tests, in accurately measuring Alzheimer's-related proteins, including amyloid-beta.
The story "Samsung to invest $10 million in US-based C2N Diagnostics" has 363 words across 19 sentences, which will take approximately 2 - 4 minutes for the average person to read.
Which news outlet covered this story?
The story "Samsung to invest $10 million in US-based C2N Diagnostics" was covered 6 hours ago by Korea Economic Daily, a news publisher based in South Korea.
How trustworthy is 'Korea Economic Daily' news outlet?
Korea Economic Daily is a fully independent (privately-owned) news outlet established in 1964 that covers mostly economy news.
The outlet is headquartered in South Korea and publishes an average of 9 news stories per day.
It's most recent story was published 1 hours ago.
What do people currently think of this news story?
The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.
How do I report this news for inaccuracy?
You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
